Revolution Medicines's market cap is currently ―. The company's EPS TTM is $-3.774; its P/E ratio is -8.40; Revolution Medicines is scheduled to report earnings on May 6, 2024, and the estimated EPS forecast is $-0.75. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 742.00K	-	$ 3.82M	$ 7.01M	$ 15.33M
Gross Profit	$ 742.00K	-	$ 3.82M	$ 7.01M	$ 15.33M
EBIT	$ -161.19M	$ -112.30M	$ -98.30M	$ -75.16M	$ -61.71M
EBITDA	$ -166.97M	$ -115.26M	$ -98.00M	$ -76.17M	$ -58.91M
Net Income Common Stockholders	$ -161.54M	$ -108.43M	$ -98.30M	$ -68.10M	$ -56.51M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 1.85B	$ 813.20M	$ 909.49M	$ 909.80M	$ 644.94M
Total Assets	$ 2.06B	$ 984.23M	$ 1.07B	$ 1.07B	$ 811.93M
Total Debt	$ 87.94M	$ 62.85M	$ 63.26M	$ 63.60M	$ 64.20M
Net Debt	$ -1.77B	$ -750.35M	$ -846.23M	$ -846.20M	$ -580.74M
Total Liabilities	$ 235.51M	$ 146.77M	$ 142.87M	$ 121.03M	$ 126.74M
Stockholders Equity	$ 1.83B	$ 837.46M	$ 930.87M	$ 952.22M	$ 685.19M
Cash Flow	-
Free Cash Flow	$ -122.88M	$ -103.03M	$ 300.00K	$ -64.12M	$ -64.66M
Operating Cash Flow	$ -120.56M	$ -100.50M	$ 300.00K	$ -62.36M	$ -61.79M
Investing Cash Flow	$ -380.40M	$ 77.35M	-	$ 4.00M	$ -7.10M
Financing Cash Flow	$ 839.35M	$ 1.01M	-	$ 324.20M	$ 51.36M

Currency in USD

Revolution Medicines Earnings and Revenue History

Income Statement >

Revolution Medicines Debt to Assets

Balance Sheet >

Revolution Medicines Cash Flow

Cash Flow >

Revolution Medicines Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing